nifedipine has been researched along with Dyskinesia, Medication-Induced in 10 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 9.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 9.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 5.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 5.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "We examined whether nifedipine, a calcium channel antagonist, added to a stable regimen of neuroleptic medication would affect cognition in patients with chronic schizophrenia or schizoaffective disorder who had tardive dyskinesia." | 5.08 | Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia. ( Deutsch, SI; Fay-McCarthy, M; Kendrick, K; Rosse, RB; Schwartz, BL, 1997) |
| "In an open label study, two fixed doses of nifedipine (30 mg and 60 mg daily) were added to the usual antipsychotic drug treatments of 10 patients suffering from chronic schizophrenia." | 5.07 | Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. ( Eyles, D; Pond, SM; Stedman, TJ; Welham, JL; Whiteford, HA, 1991) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 5.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 1.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| "Nifedipine treatment resulted in variable improvement in tardive dyskinesia in eight geriatric psychiatric patients." | 1.28 | Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients. ( Kushnir, SL; Ratner, JT, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cates, M | 1 |
| Lusk, K | 1 |
| Wells, BG | 1 |
| Yamada, K | 2 |
| Kanba, S | 2 |
| Ashikari, I | 2 |
| Ohnishi, K | 1 |
| Yagi, G | 2 |
| Asai, M | 2 |
| Onishi, K | 1 |
| Schwartz, BL | 1 |
| Fay-McCarthy, M | 1 |
| Kendrick, K | 1 |
| Rosse, RB | 1 |
| Deutsch, SI | 1 |
| Soares, KV | 1 |
| McGrath, JJ | 1 |
| Stedman, TJ | 1 |
| Whiteford, HA | 1 |
| Eyles, D | 1 |
| Welham, JL | 1 |
| Pond, SM | 1 |
| Suddath, RL | 1 |
| Straw, GM | 1 |
| Freed, WJ | 2 |
| Bigelow, LB | 1 |
| Kirch, DG | 1 |
| Wyatt, RJ | 1 |
| Duncan, E | 1 |
| Adler, L | 1 |
| Angrist, B | 1 |
| Rotrosen, J | 1 |
| Cadet, JL | 1 |
| Taylor, E | 1 |
| Kushnir, SL | 1 |
| Ratner, JT | 1 |
2 reviews available for nifedipine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Are calcium-channel blockers effective in the treatment of tardive dyskinesia?
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dyskinesia, | 1993 |
Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Calcium Channel Blockers; Diltiazem; Dyskinesia, Drug-Induced; Humans; Nifedip | 2000 |
5 trials available for nifedipine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off.
Topics: Adult; Aged; Calcium Channel Blockers; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dys | 1996 |
Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia.
Topics: Aged; Calcium Channel Blockers; Cognition; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug | 1997 |
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperido | 1991 |
A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Benztropine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Hum | 1991 |
Nifedipine in the treatment of tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Neurologic Examina | 1990 |
3 other studies available for nifedipine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Effectiveness of nilvadipine in two cases of chronic schizophrenia.
Topics: Calcium Channel Blockers; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Nife | 1995 |
The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
Topics: Animals; Binding Sites; Brain; Calcium; Dihydropyridines; Dyskinesia, Drug-Induced; Female; Ion Chan | 1988 |
Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients.
Topics: Age Factors; Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Hypertension; Male; | 1989 |